What is Decentralized Science (DeSci)?

DeSci provides a censorship-resistant structure that democratizes scientific funding and management. Instead of relying on traditional grants and venture capital, researchers can raise funds, document their work, and manage their IP on the blockchain.

How Does VitaDAO Work?

VitaDAO is a community-driven DAO supporting early-stage longevity research. Its members include academic scientists, pharmaceutical companies (such as Pfizer), and key figures from the crypto space (like Balaji Srinivasan). VITA token holders can vote on funding and governance decisions.

Through the Molecule platform, researchers can register their work on the blockchain in IP-NFT format. These IPs can be tokenized into IPT and sold to investors.

IP-NFT and IPT: Revolutionizing Scientific Funding

• IP-NFTs allow researchers to tokenize their intellectual property on the blockchain, enabling funding through NFT sales.
• IPTs are fractionalized versions of IP-NFTs, allowing broader participation in research governance.
• VITA-FAST, VitaDAO’s first IPT project, funds studies on cellular rejuvenation.

VitaDAO’s Role in BioPharma

• Enhanced collaboration and liquidity: Researchers can verify IP ownership through NFTs and share their work with other labs.
• More efficient and cost-effective drug development: IPTs give patients and researchers more control over project governance.
• Increased project visibility: Through the Molecule partnership, researchers can present their work to a wider investor base.

You Might Be Interested In: Elon Musk Talks About the Name of a New Memecoin!

VitaDAO Team

VitaDAO is led by experts in longevity and biotech who contribute to the DeSci ecosystem with their diverse skill sets.

• Tim Peterson – Dealflow Steward
  Based in Cambridge, Massachusetts, Peterson is a Harvard graduate and previously served as CTO and co-founder of Leangap.
• Laurence Ion – Dealflow Steward
  Operating from Texas, Earth, Ion was previously the founder of Intersect and CEO/co-founder of Wabbit.
• Alex Dobrin – Awareness Steward
  Located in Bucharest, Romania, Dobrin graduated from the University of Bucharest and previously worked as CPO and developer at Wabbit.
• Sebastian Brunemeier – Longevity Working Group
  Based in Oxford, UK, Brunemeier studied Life Science Business Management at Vrije Universiteit Amsterdam. He co-founded Cambrian Biopharma, Samsara Therapeutics, and Cyclone Therapeutics.
• Matthew ‘Oki’ O’Connor – Senior Reviewer
  Residing in Richmond, California, O’Connor studied biochemistry at Baylor College of Medicine.

This team drives VitaDAO’s growth and fosters innovation in longevity research.

Funding and Investors

To date, VitaDAO has raised $11.2M in funding. Investors include Tioga Capital Partners, L1D, Balaji Srinivasan, Shine Capital, and Pfizer Venture Investments.

Funding rounds:

• $2M (November 2023)
• $3.6M (January 2023)
• $500K (August 2022, led by Pfizer)
• $5.1M (June 2021, pre-seed round)

Additionally, VitaDAO invests in projects like ImmuneAGE Bio and Gero, further expanding the DeSci ecosystem.

VITA Tokenomics

The total supply of VITA tokens is 64,298,880. Distribution:

• 57.7% reserved for treasury
• 42.3% allocated to different groups:
  • 10% Gnosis Token Auction
  • 12.5% DAO working groups
  • 10% service providers
  • 9.8% strategic investors

With VitaDAO, scientific research funding and management become decentralized. Through blockchain technology, researchers and supporters can invest in innovative projects using IP-NFT and IPT systems. Check out the whitepaper, join the community, or learn more through the links below.

Whitepaper: VitaDAO Whitepaper
X (Twitter): VitaDAO X
Telegram: VitaDAO Telegram

You can also freely share your thoughts and comments about the topic in the comment section. Additionally, don’t forget to follow us on our Telegram, YouTube, and Twitter channels for the latest news and updates.

The post What is VitaDAO (VITA)? appeared first on Coin Engineer.